Burrowing through the heterogeneity: Review of mouse models of PTCL-NOS
Currently, there are nineteen different PTCL entities recognized by the World Health Organization; however, approximately 70 percent of PTCL diagnoses fall within one of three subtypes (i.e. peripheral T-cell lymphoma not otherwise specified [PTCL-NOS], anaplastic large-cell lymphoma, and angioimmun...
Main Authors: | Christine E Cutucache, Tyler Andrew Herek |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00206/full |
Similar Items
-
The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS)
by: Yafei Zhang, et al.
Published: (2021-10-01) -
Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine
by: Yumeng Zhang, et al.
Published: (2020-06-01) -
Sarcoidosis-Lymphoma Syndrome Associated with Folliculotropic Peripheral T Cell Lymphoma Not Otherwise Specified
by: Saaya Yoshida, et al.
Published: (2017-04-01) -
Peripheral T cell lymphoma after chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): a case report
by: Xiao-hang Liu, et al.
Published: (2019-11-01) -
Pralatrexate for Prolonged Treatment of Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, with Prophylactic Leucovorin
by: Koichi Kitazume, et al.
Published: (2019-07-01)